Search

Candida auris (C.auris) infections are a major global health challenge, with nosocomial outbreaks on the rise and many strains exhibiting resistance to antifungal agents. New real-time PCR tests enable sensitive and specific identification of the pathogen and of the most important mutations associated with resistance to echinocandins (ECH).

Innovative 3D in vitro microphysiological test systems improve the understanding of host-pathogen interactions and the evaluation of antimicrobial treatments, a potential aid in the fight against infections and resistance

New blood test developed by Siemens Healthineers in collaboration with Novartis aims to improve the management of MS

Aivia's improved deep learning model from Leica Microsystems accelerates cell detection by up to 78%

Ready-to-use kit from Gyros Protein Technologies enables the detection of binding antibodies against AAV vectors without the need for serotype-specific assays

Explore the modern point-of-care ecosystem and its impact on healthcare delivery

Learn about clinical aspects of Graves’ Disease and the use of TSH immunoglobulin assay for diagnosis and monitoring